Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duloxetine effects on VLPP and EMG in SUI
NCT00190853Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Jan 2005
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of duloxetine in stress urinary incontinence (SUI), sponsored by Eli Lilly and Company. Started Jan 2005; status: completed.
02
Drugs
duloxetine
03
Conditions
stress urinary incontinence (SUI)
Beyond the preview
Go deeper on NCT00190853.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00190853.